Clinical Trials in Philadelphia

Showing 3521-3540 of 20,904 trials

Enrolling By InvitationPhase 2/3< 1 mile

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

NCT05883748

This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in participants with EPP.

Erythropoietic Protoporphyria

Disc Medicine, Inc230 participantsStarted Aug 2023

Birmingham, Alabama, United States • San Francisco, California, United States • Miami, Florida, United States +10 more locations

RECRUITINGPhase 1/2< 1 mile

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

NCT04068597

A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 (inobrodib) in patients with Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukaemia or High Risk Myelodysplastic syndrome.

Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more

CellCentric Ltd.250 participantsStarted Aug 2019

Atlanta, Georgia, United States • Indianapolis, Indiana, United States • Bethesda, Maryland, United States +36 more locations

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Find Trials by Condition in Philadelphia

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer

Blue Light Cystoscopy With Cysview® Registry

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

A Trial of Varenicline for E-cigarette Cessation

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

Study of Aspirin in Patients With Vestibular Schwannoma

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors